Suchergebnisse - "Sarilumab"

PubPharm (130)

91

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

enthalten in: Arthritis Research & Therapy | 2020

von Gabay, C. | Burmester, G. | Strand, V. | +8

92

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

enthalten in: Inflammation and regeneration | 2020

von Hashizume, M.

93

An Update on Current Therapeutic Drugs Treating COVID-19

enthalten in: Current pharmacology reports | 2020

von Wu, R. | Wang, L. | Kuo, H. | +11

CommentIn: Expert Opin Biol Ther. 2020 Oct;20(10):1111-1116. - PMID 32762581

94

Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

in: Arthritis Research & Therapy | 2020

von Mark C. Genovese | Gerd R. Burmester | Owen Hagino | +6

95

Sarilumab use in severe SARS-CoV-2 pneumonia

in: EClinicalMedicine | 2020

von Elisa Gremese | Antonella Cingolani | Silvia Laura Bosello | +38

96

Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies

in: Arthritis Research & Therapy | 2020

von Mark C. Genovese | Roy Fleischmann | Alan Kivitz | +6

97

Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge

in: International Journal of Infectious Diseases | 2020

von Pranay Sinha | Anahita Mostaghim | Catherine G. Bielick | +14

98

Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19

in: Infectious Diseases and Therapy | 2020

von Joseph Meletiadis | Sotirios Tsiodras | Panagiotis Tsirigotis

99

High levels of interleukin-6 in patients with rheumatoid arthritis are associated with greater improvements in health-related quality of life for sarilumab compared with adalimumab

in: Arthritis Research & Therapy | 2020

von Vibeke Strand | Susan H. Boklage | Toshio Kimura | +3

100

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

in: Inflammation and Regeneration | 2020

von Misato Hashizume

[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[13]